Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics?

Literature DB >> 7485260

What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics?

K Neiswanger, B B Kaplan, S Y Hill.

Abstract

Entities: Disease Gene

Mesh：

Substances：
Receptors, Dopamine D2

Year: 1995 PMID： 7485260 DOI： 10.1002/ajmg.1320600403

Source DB: PubMed Journal: Am J Med Genet ISSN： 0148-7299

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors: Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal: Med Hypotheses Date: 2014-02-26 Impact factor: 1.538

Review 2. Candidate gene-environment interaction research: reflections and recommendations.

Authors: Danielle M Dick; Arpana Agrawal; Matthew C Keller; Amy Adkins; Fazil Aliev; Scott Monroe; John K Hewitt; Kenneth S Kendler; Kenneth J Sher
Journal: Perspect Psychol Sci Date: 2015-01

3. Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

Authors: Yunlong Ma; Wenji Yuan; Xianzhong Jiang; Wen-Yan Cui; Ming D Li
Journal: Mol Neurobiol Date: 2014-08-20 Impact factor: 5.590

4. GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM^™): LESSONS LEARNED FROM AMERICA.

Authors: Kenneth Blum; Edward J Modestino; Marjorie C Gondré-Lewis; Jennifer Neary; David Siwicki; Mary Hauser; Debmalya Barh; Bruce Steinberg; Rajendra D Badgaiyan
Journal: Precis Med (Bangalore) Date: 2017-11-18

Review 5. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

Authors: Kenneth Blum; Thomas J H Chen; B William Downs; Abdalla Bowirrat; Roger L Waite; Eric R Braverman; Margaret Madigan; Marlene Oscar-Berman; Nicholas DiNubile; Eric Stice; John Giordano; Siobhan Morse; Mark Gold
Journal: Postgrad Med Date: 2009-11 Impact factor: 3.840

6. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Authors: I D Waldman; D C Rowe; A Abramowitz; S T Kozel; J H Mohr; S L Sherman; H H Cleveland; M L Sanders; J M Gard; C Stever
Journal: Am J Hum Genet Date: 1998-12 Impact factor: 11.025

What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics?

1. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Review 2. Candidate gene-environment interaction research: reflections and recommendations.

3. Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

4. GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM^™): LESSONS LEARNED FROM AMERICA.

Review 5. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

6. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

7. Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.

Review 8. Genetic influences on smoking: candidate genes.

9. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.

What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics?

1. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Review 2. Candidate gene-environment interaction research: reflections and recommendations.

3. Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions.

4. GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™): LESSONS LEARNED FROM AMERICA.

Review 5. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).

6. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

7. Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.

Review 8. Genetic influences on smoking: candidate genes.

9. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.

4. GLOBAL OPIOID EPIDEMIC: DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM^™): LESSONS LEARNED FROM AMERICA.